baber/WOPTO huggingface dataset:
Patent EP-3921135-A1 (EP)
Title: Lamellenblock mit lamellendurchbrüchen
Inventor: ESSWEIN MICHAEL
IPC: B33Y10/00
Filed: 2020-02-13
Abstract: Es wird ein Lamellenblock (100) für eine Kalibriereinrichtung zur Kalibrierung eines extrudierten Profils bereitgestellt, wobei der Lamellenblock (100) eine Lamellenstruktur (110) umfasst, welche eine Vielzahl von Lamellen (112) aufweist, die durch Nuten (114) voneinander beabstandet und in Längsrichtung des Lamellenblocks (100, 100a) angeordnet sind. Wenigstens einige der Lamellen (112) sind mit wenigstens einem Lamellendurchbruch (115) mit vorgegebener variabler Geometrie versehen. Ferner wird ein Verfahren zur Herstellung des oben genannten Lamellenblocks (100) sowie eine Kalibriereinrichtung, die eine Vielzahl der oben genannten Lamellenblöcke umfasst, bereitgestellt. Weiterhin wird ein System zur additiven Fertigung des oben genannten Lamellenblocks (100) ein entsprechendes Computerprogramm und entsprechender Datensatz bereitgestellt.
Patent EP-3946620-A1 (EP)
Inventor: COATES DAVID ANDREW
IPC: A61K31/407
Filed: 2020-03-19
Abstract: The present invention provides novel crystalline salt forms of 6,6-dimethyl-2-{2-[(1-methyl-1H-pyrazol-5-yl)amino]pyrimidin-4-yl}-5-[2-(morpholin-4-yl)ethyl]-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one.
Patent EP-3969667-A1 (EP)
Inventor: ZANGANI DONATO
IPC: E02B3/04
Filed: 2020-05-06
Abstract: L'invention concerne une structure modulaire tubulaire (géotube) pour la protection côtière, le géotube étant obtenu au moyen d'une feuille pourvue de bords longitudinaux opposés (32, 33) comportant au moins en partie des dents de couplage libérables conçues pour coopérer l'une avec l'autre afin d'assurer un couplage mécanique entre les bords longitudinaux (32, 33).
Patent EP-3987530-A1 (EP)
Inventor: WIANT MATTHEW
IPC: G16H50/30
Filed: 2020-04-10
Abstract: Embodiments provide functionality for determining fitness level of an individual using a fitness testing unit. In one such embodiment, an individual is instructed, via a graphical user interface (GUI) of a fitness testing unit, to perform a series of exercise activities. In turn, via the fitness testing unit, baseline heart rate, maximum heart rate, and recovery heart rate are captured while the individual is performing the series of exercise activities. Then, a fitness level of the individual is determined using an age of the individual and the captured baseline heart rate, maximum heart rate, and recovery heart rate.
Patent EP-3953040-A1 (EP)
Inventor: BUATHIER YOANN
IPC: B01L3/00
Filed: 2020-03-31
Abstract: The invention relates to a device (1) for determining the presence of a contamination of microorganisms in a fluid, said device (1) comprising a casing (2) comprising an inner volume, a cover (3) closing the casing, a fluid inlet port (11), at least one filtration member (4), at least one nutritive layer (5) comprising a composition of a microbiological growth medium, characterized in that the device comprises a fluid outlet port (12) and in that the cover (3) comprises an inner surface within the inner volume that extends radially around the fluid inlet port (11) up to a peripheral edge of the cover, the inner surface being inclined and converging toward the fluid inlet port (11) and in that the bottom of the casing (2) comprises a surface extending radially around the fluid outlet port (12) up to the lateral wall of the casing, the inner surface being inclined and converging toward the fluid outlet port (12).
Patent EP-3986517-A1 (EP)
Inventor: GERLACH ANGELA
IPC: F04D25/08
Filed: 2020-05-18
Abstract: Die Erfindung betrifft eine Lüftereinheit (1, 20) für ein Beatmungsgerät, aufweisend ein Gehäuse (2) mit einem Saugstutzen (3, 21, 23, 24), der einen Einlasskanal (4) zum saugseitigen Einströmen eines Fluids in das Gehäuse (2) bildet, und einem Druckstutzen (5), der einen Auslasskanal (6) zum druckseitigen Ausströmen des Fluids aus dem Gehäuse (2) bildet, sowie ein in dem Gehäuse (2) drehbar gelagertes Lüfterrad (7), das ausgebildet und angeordnet ist, durch Rotation das Fluid über den Saugstutzen (3, 21, 23, 24) anzusaugen und durch den Einlasskanal (4) in das Gehäuse (2) zu fördern sowie das Fluid über den Druckstutzen (5) wieder auszustoßen und durch den Auslasskanal (6) aus dem Gehäuse (2) zu fördern, wobei der Saugstutzen (3, 21, 23, 24) an seiner dem Einlasskanal (4) zugewandten, einen Einlasskanalnenndurchmesser (D N ) bestimmenden Innenfläche wenigstens ein Strömungsleitelement (10, 22, 25, 26) aufweist, mittels welchem ein vom Einlasskanalnenndurchmesser (D N ) abweichender Einlasskanalinnendurchmesser (D I ) festgelegt ist.
Patent EP-3997849-A1 (EP)
Title: Transport de données de clé de chiffrement utilisée pour sécuriser une communication entre des dispositifs informatiques
Inventor: SCHOUVILLER KYLE
IPC: H04L29/06
Filed: 2020-05-21
Abstract: La présente invention concerne des opérations de traitement configurées de sorte à permettre à un client et à un serveur d'établir une communication sécurisée lors d'une connexion initiale entre le client et le serveur. Lors d'une connexion initiale avec le serveur, le client fournit un jeton chiffré qui sert à la fois de preuve d'authentification/d'identité et fournit, dans le jeton chiffré, une clé de chiffrement que le serveur peut utiliser pour établir une communication sécurisée avec le client. Le serveur peut faire confiance au jeton chiffré et à la clé de chiffrement car le jeton chiffré est signé et chiffré par un service d'authentification qui a une relation de confiance avec le serveur et parce que le service d'authentification a des clés de déchiffrement et de vérification de signature pré-partagées avec le serveur. Le serveur utilise la clé cryptée pour sécuriser les communications avec le client sans nécessiter de traitement supplémentaire pour consulter l'identité du client ni tout autre intervention du service d'authentification.
Patent EP-3969390-A1 (EP)
Inventor: RIOLFO NICOLA
IPC: B65D75/20
Filed: 2020-05-13
Abstract: Described herein is a package (10) for a foodstuff product, in particular a confectionery product, comprising a wrapping sheet (2) wrapped around said product (P) so as to enclose it within a cavity (C) delimited by said sheet and so as to remain adherent to the outer surface of said product (P). The package is characterized in that it envisages a sealing portion (4), which is folded adherent to the portion of the sheet that defines the inner cavity (C) and which is provided with a point (6) of facilitated opening.
Patent EP-4003049-A1 (EP)
Inventor: HAMMER BENEDIKT
IPC: A23K20/105
Filed: 2020-06-25
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zur Fütterung von Geflügel während der Aufzucht, während der Haltung oder in der Mast des Geflügels, in dem Guanidinoessigsäure oder ein Salz hiervon als Futtermittelzusatz verabreicht wird.
Patent EP-4171813-A1 (EP)
Inventor: BRUELHART ANDRÉ
IPC: B01L3/00
Filed: 2020-06-26
Abstract: The present application relates to a microfluidic chip for a biological or medical staining or assay. The microfluidic chip comprises a base plate with a first main side and a second main side, a reaction chamber which is open towards said first main side, means for affixing a slide on said reaction chamber in a fluid-tight manner, at least one first channel connecting at least one input opening with the reaction chamber and at least one second channel connecting the reaction chamber to a waste. The at least one first channel comprises at least one solution in a quantity which is sufficient to carry out the staining or assay in the reaction chamber. Further, the present application also relates to a pumping device comprising a seat for a microfluidic chip as described above and a pump. The seat is configured such that at least one outlet of the pump is connectable to at least one input opening of a microfluidic chip arranged in said seat in order to pump a fluid into said at least one input opening by means of the pump.
Patent EP-3982861-A1 (EP)
Title: Extraction de substance présente dans des lumières corporelles
Inventor: NGUYEN HOAI
IPC: A61B18/14
Filed: 2020-06-11
Abstract: L'extraction d'une substance présente dans des lumières vasculaires peut être améliorée par utilisation d'un élément distal comprenant une maille expansible, un dispositif de traitement comprenant un élément allongé ayant une partie proximale et une partie distale conçu pour être positionné à l'intérieur d'un vaisseau sanguin au niveau d'un site de traitement au niveau ou à proximité d'un thrombus. Un élément distal comprenant une maille expansible est accouplé à la partie distale de l'élément allongé par l'intermédiaire d'un ensemble de raccordement. Dans un état expansé, au moins une partie de la maille est conçue pour être en apposition avec la paroi de vaisseau sanguin au niveau du site de traitement pour ancrer ou stabiliser l'élément allongé par rapport au vaisseau sanguin. L'élément distal peut être couplé électriquement à un générateur de courant extracorporel.
Patent EP-3990631-A1 (EP)
Inventor: BREITKOPF LOTHAR
IPC: C12N15/10
Filed: 2020-06-26
Abstract: The present invention provides a poly(alkylene oxide) polymer based size selective nucleic acid enrichment method for enriching target nucleic acid molecules from a nucleic acid containing sample which comprises target nucleic acid molecules and non-target nucleic acid molecules, wherein the target nucleic acid molecules are longer than the non-target nucleic acid molecules, the method comprising (a) preparing a binding mixture comprising - the nucleic acid containing sample, - a poly(alkylene oxide) polymer and - a salt and binding nucleic acid molecules to a solid phase which comprises a functional group, preferably carboxylated magnetic particles, wherein the bound nucleic acid molecules comprise target nucleic acid molecules; (b) preferably separating the solid phase with the bound nucleic acid molecules from the remaining sample; (c) contacting the solid phase with the bound nucleic acid molecules at least once with a reagent composition comprising a poly(alkylene oxide) polymer and a salt to selectively elute non-target nucleic acid molecules, wherein the concentration (w/v) of the poly(alkylene oxide) polymer in the reagent composition of step (c) is lower than the concentration (w/v) of the poly(alkylene oxide) polymer in the binding mixture of step (a); (d) optionally washing the bound target nucleic acid molecules; and (e) eluting the bound target nucleic acid molecules from the solid phase. Said method allows the size selective purification of target DNA molecules and is particularly suitable for sequencing applications. It is more time-and cost efficient than prior art methods and provides excellent purification results. Moreover, further methods and kits are provided.
Patent EP-3908306-A1 (EP)
Inventor: CREWS CRAIG
IPC: C07D419/02
Filed: 2020-01-08
Abstract: The present invention provides bifunctional compounds that efficiently dephosphorylate certain phospho-activated target proteins. Such target proteins can be any protein involved in the pathway of a disease or disorder, such as but not limited to cancer, neurodegeneration, metabolic disease, diabetes, insulin resistance, and so forth.
Patent EP-3908919-A1 (EP)
Inventor: MOULD JOHN
IPC: G06F7/60
Filed: 2020-01-13
Abstract: L'invention concerne un procédé pour la discrétisation d'un modèle complexe utilisant des fenêtres de calcul pour définir la physique, le type de résolution (explicite/implicite), le maillage (type/densité) et le pas de temps utilisés dans des domaines spatiaux distincts pour l'analyse par éléments finis. Les fenêtres peuvent être définies manuellement ou automatiquement et peuvent être exploitées pour réduire l'énergie de calcul globale et le temps nécessaire pour résoudre le modèle.
Patent EP-3994132-A1 (EP)
Title: Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
Inventor: SIDDIQUI-JAIN ADAM
IPC: A61P3/10
Filed: 2020-07-02
Abstract: Provided herein is a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein values for the variables (e.g, X1, X2, R1, R2, R3, R4, R5, R6, R7, R8, m, n) are as described herein. Compounds of Formula I, pharmaceutically acceptable salts thereof, pharmaceutical compositions of either of the foregoing, and combinations of any of the foregoing can be used to treat tyrosine kinase non- receptor 1 (TNK1)-mediated diseases, disorders and conditions.
Patent EP-3924160-A1 (EP)
Inventor: LI SHENSHEN
IPC: C08G63/02
Filed: 2020-01-27
Abstract: A composition includes a polymer, a functional component, and an oxidation catalyst. The functional component may be an oxidizable additive or a precursor thereof. The oxidizable additive includes an organic moiety including a first carbon atom (C1) attached to a hydrogen (H), a first group having a conjugated unit (a double bond, a triple bond, an aromatic ring); a second group having a heteroatom (including C=N, N=O, C=O, an O, a N, a fragment having at least three heteroatoms (including a N) within a spatial distance of 4Å from C1); and a third group (hydrogen, alkyl group, aromatic group, a double bond, a triple bond, and a heteroatom). The C1 may be attached to a strong mesomeric electron-donating group and a strong mesomeric electron-withdrawing group; or to a conjugated group and a mesomeric group. The functional component may be derived from a recycled plastic article.
Patent EP-3843101-A1 (EP)
Inventor: HAN BUHM
IPC: G16B30/00
Filed: 2020-01-10
Abstract: A method for predicting a genotype using SNP data is disclosed. An embodiment includes steps of receiving SNP data to be analyzed and reference data, of updating the reference data by inserting a marker corresponding to a genotype of the SNP data corresponding to each of a plurality of predetermined regions included in corresponding SNP data, for each SNP data included in the reference data, and of predicting a genotype of the SNP data to be analyzed based on the SNP data to be analyzed and the updated reference data.
Patent EP-3918957-A1 (EP)
Inventor: FUJISAWA KAZUNORI
IPC: G06Q10/08
Filed: 2020-01-29
Abstract: An object is to increase a locker turnover rate related to a locker management system. A locker management system including a management server that manages a status of shipping of items from distribution centers to a plurality of locker spots, and a status of keeping each of the items at each of the locker spots for a predetermined length of time. The locker spot is equipped with an electronically controlled locker, and the management server receives selection and designation of the locker spot to keep the item upon order of the item from a customer terminal and designation of the predetermined length of time for which the item is kept at the locker spot, and upon detection of delivery of the item to the locker spot, notifies the customer terminal of a locker number of the electronically controlled locker. When a customer visits the locker spot and reads a two-dimensional code attached to the locker, and transmits this code and the customer ID to the management server in order to unlock the locker using the customer terminal, the management server performs necessary checking processing. If the answer of the checking processing is positive, a signal for unlocking the locker is transmitted to the locker.
Patent EP-3921082-A1 (EP)
Inventor: BITTERFIELD DEBORAH LEE
IPC: C12M1/32
Filed: 2020-02-05
Abstract: Described herein are isolated cell culture components such as, e.g., biologics and/or lipids, and methods for isolating cell culture components from a liquid cell culture medium. Methods of the present invention may include contacting a dehydration composition and a liquid cell culture medium comprising a target component to form a mixture; forming an at least partially dehydrated component in the mixture; and separating the at least partially dehydrated component from the mixture, thereby providing an isolated component. In some embodiments, the isolated component comprises the at least partially dehydrated component. In some embodiments, the isolated component is present in a composition (e.g., liquid phase) separated from the at least partially dehydrated component.
Patent EP-3897598-A1 (EP)
Inventor: HALSTEAD JOSEPH
IPC: A61K47/10
Filed: 2020-02-05
Abstract: A method involves dissolving a curcuminoid in glycerol to make an administrable solution. An alkali salt is added to the glycerol to increase the solubility of the curcuminoid in the glycerol to more than 20 milligrams curcuminoid per millilitre of glycerol (and up to in excess of 200 milligrams curcuminoid per millilitre of glycerol with the addition of sufficient alkali salt in embodiments). The resulting administrable solution can be administered (such as by way of intramuscular injection) as is without the need of an aqueous emulsion and can be stored for more than 24 hours without curcuminoid precipitation.
Patent EP-4048198-A1 (EP)
Title: Endoprothèse stent de branche et dispositif de pose pour le traitement endovasculaire d'anévrismes de l'artère iliaque
Inventor: BERTINI TIMOTHY
IPC: A61F2/07
Filed: 2020-07-22
Abstract: Les techniques de la présente invention concernent de manière générale un dispositif de branche iliaque ayant un corps iliaque externe, une branche iliaque commune et une branche iliaque interne. Un diamètre de l'ouverture proximale de la branche iliaque commune est supérieur à un diamètre d'une ouverture distale du corps iliaque externe. Le dispositif de branche iliaque est configuré pour être déployé sans s'élever au-dessus et sur la bifurcation aortique et sans utiliser une certaine forme d'accès antérograde supra-aortique, par exemple par l'intermédiaire d'un accès à l'artère brachiale ou axillaire. Ceci simplifie la procédure, réduit le temps de procédure, en maximisant ainsi le taux de réussite de la procédure, et permet de mettre en œuvre la procédure sur une large population de patients.
Patent EP-4022757-A1 (EP)
Inventor: ESTEGHLAL GHOLAMABAS
IPC: H02M3/158
Filed: 2020-08-10
Abstract: Die vorliegende Erfindung schafft eine Regelung eines Gleichspannungskonverters (10) mit mehreren Gleichspannungswandler-Modulen (4-1, 4-2). Hierzu wird für alle Gleichspannungswandler-Module eine zentrale Regelgröße für ein spannungsgesteuertes Regeln des Gleichspannungskonverters generiert. Darüber hinaus kann für jedes Gleichspannungswandler-Modul zusätzlich eine strombasierte Regelgröße generiert werden. Durch die Kombination der spannungsbasierten Regelgröße und der strombasierten Regelgröße kann die Ausgangsleistung, insbesondere der Ausgangsstrom jedes Gleichspannungswandler-Moduls individuell angepasst werden. Auf diese Weise kann eine Überlastung der Gleichspannungswandler-Module vermieden werden.
Patent EP-3931783-A1 (EP)
Inventor: HOLMES ALAN D
IPC: G06Q20/40
Filed: 2020-02-26
Abstract: Systems and methods for processing payment transfers are disclosed. The system may allow senders to remit payments to receivers. The system may receive a payment request. The system may execute a payment risk analysis on the payment request to determine a risk assessment. Based on the risk assessment, the system may invoke a payment processor to complete the payment request. The payment processor may transmit a debit pull to a sender bank. In response to receiving the debit pull the sender bank may debit the payment amount from a sender account from the sender data. The payment processor may transmit a credit push to a receiver bank. In response to receiving the credit push the receiver bank may credit the payment amount to a receiver account from the receiver data.
Patent EP-4017567-A1 (EP)
Inventor: SPATARO JOSEPH
IPC: A61M25/00
Filed: 2020-08-18
Abstract: A catheter adapter may include a catheter adapter body (216) and a catheter adapter channel (221) formed within the catheter adapter body. The catheter adapter body may include a proximal end (220), a distal end (218), an inferior surface (240), and a superior surface (242). The inferior surface of the catheter adapter body may be configured to abut against a surface area of a patient's skin, and an angle (260) formed between the surface area of the patient's skin and a longitudinal axis of the catheter adapter channel may be greater than 4 degrees.
Patent EP-3797341-A1 (EP)
Inventor: Li wen zheng
IPC: G05D1/02
Filed: 2020-03-27
Abstract: Embodiments herein disclose methods and systems for generating 2D-navigation map for collision-free navigation by plurality of robots. Initially, 2D-navigation map generator executing at a cloud map server initiates particle simulation to add plurality of bubbles to an image of an area. Next the 2D-navigation map generator executing at cloud map server, process the bubble simulation to determine set of bubbles from the plurality of robots on the image that overlap free spaces of the area in the image. Next 2D-navigation map generator executing at the cloud map server, generates 2D-navigation map by connecting the set of bubbles using a plurality of edges, wherein the plurality of edges indicate a navigation path to navigate within the area. Finally, based on the generated 2D-navigation map, the plurality of robots traversing from a current location to another location.
Patent EP-3967751-A1 (EP)
Inventor: HU SHENGSHOU
IPC: C12N5/077
Filed: 2020-04-02
Abstract: Provided are a composition containing (-)-Blebbistain and/or para-Blebbistain, a kit comprising the composition, and a cardiomyocyte culture method using the composition as a culture medium. Also provided is a use of (-)-Blebbistain and/or para-Blebbistain in preparation of a cardiomyocyte isolation reagent or cardiomyocyte culture reagent.
Patent EP-3952484-A1 (EP)
Title: Power control method, apparatus and system
Inventor: YAO KE
IPC: H04W52/14
Filed: 2020-03-23
Abstract: The present application provides a power control method, apparatus and system. The power control method comprises: obtaining an association between at least one piece of spatial domain resource information and a power control parameter; obtaining the spatial domain resource information of an uplink transmission; and determining the power control parameter of the uplink transmission according to the spatial domain resource information of the uplink transmission and the association between the at least one piece of spatial domain resource information and the power control parameter, the spatial domain resource information comprising at least one of control resource set (CORESET) information, transmitter receiver point (TRP) information, and physical uplink control channel (PUCCH) resource information.
Patent EP-3958901-A1 (EP)
Inventor: SONG WENCHAO
IPC: C07K16/46
Filed: 2020-04-24
Abstract: La présente invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5 ou d'une protéine de fusion de celui-ci. Spécifiquement, l'invention concerne des procédés de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par mise en contact de l'individu avec une protéine de fusion d'anticorps anti-C5 de celui-ci.
Patent EP-3962532-A1 (EP)
Title: Compositions comprising a tweak ligand and methods of using same
Inventor: SEROOGY KIM B
IPC: B82Y5/00
Filed: 2020-04-29
Abstract: The instant disclosure relates to nanoparticle compositions that may be used for the targeting of certain cells or tissues. The nanoparticles may take a variety of different forms, including non- viral, viral, and lipid nanoparticles, and may utilize a TNF receptor superfamily member 12A ("TWEAKR") binding region of the TWEAK protein to target a nanoparticle to tissues expressing TWEAKR. The compositions may further comprise a suicide gene optionally under the control of a tissue specific promoter. In further aspects, methods of treating an individual using the disclosed nanoparticle compositions are described.